"Rozendaal chairs the trial and appellate group and is prized for his narrative gifts in the courtroom, whatever the technology at issue." - IAM Patent 1000

John Christopher "J.C." Rozendaal

Director

jcrozendaal@sternekessler.com
+1 202.772.8747
LinkedIn

Overview

John Christopher “J.C.” Rozendaal is a director and chair of Sterne Kessler’s Trial & Appellate Practice Group. J.C. focuses his practice on representing clients in complex business and intellectual property litigation, principally in federal court, and he regularly tries patent-infringement cases to juries. He frequently briefs and argues cases at the U.S. Court of Appeals for the Federal Circuit and has represented clients in the U.S. Supreme Court, both at the certiorari stage and on the merits.

J.C. has litigated patents on a wide variety of technologies, including pharmaceuticals, aseptic packaging systems, golf clubs, optical disc drives, medical ultrasound, Voice-over-Internet-Protocol, LCD flat-panel displays, and streaming video technology.

A growing part of J.C.’s practice includes counseling generic pharmaceutical companies on matters related to generic pharmaceuticals and biosimilars, as well as assisting international companies as they navigate the U.S. patent system. A seasoned litigator, J.C. is particularly adept at explaining complicated technical concepts to juries and judges who have no background in science or technology. Since 2019, he has been named an “IP Star” by Managing Intellectual Property. In 2021, J.C. became a Fellow of the American Bar Foundation, where membership is limited to just one percent of lawyers licensed to practice in each jurisdiction.

Prior to becoming a practicing attorney, J.C. served as a clerk for Judge Douglas H. Ginsburg, U.S. Court of Appeals, District of Columbia Circuit, and Justice Anthony M. Kennedy, U.S. Supreme Court.

J.C. earned his J.D. from the University of Texas School of Law, Austin, with highest honors. He received a B.A. and M.A. from Oxford University, Brasenose College, with first-class honors and a B.A. from the University of Texas, Austin, Plan II, with highest honors.

Representative Matters

  • Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al. (on behalf of Teva Pharmaceuticals, obtained district court judgment invalidating six patents protecting Restasis ophthalmic emulsion for treatment of dry eye; successfully defended judgment on appeal) (E.D. Tex. No. 2:15-cv-1455) (Fed. Cir. No. 2018-1130).
  • Steuben Foods, Inc. v. Shibuya Hoppmann Corp. et al. (currently representing Shibuya Hoppmann Corp. and other defendants in litigation involving aseptic bottling systems for low-acid foods) (W.D.N.Y) (1:10-cv-781).
  • MiiCs & Partners America, LLC et al. v. Funai Electric Co., Ltd.vet al. (on behalf of Funai Electric, obtained summary judgment of invalidity or non-infringement of five patents directed to LCD flat-panel televisions; successfully defended judgment on appeal) (D. Del. No. 1:14-cv-804) (Fed. Cir. No. 2018-1307).
  • In re Certain Audio Processing Hardware and Software and Products Containing the Same. (represented Dell Inc. in USITC investigation involving audio processing technology in first case to reach Commission in pilot program for rapid disposition of case-dispositive issues) (USITC 2015) (Inv. No. 337-TA-949).
  • Limelight Networks, Inc. v. Akamai Techs., Inc. (represented Limelight Networks in U.S. Supreme Court case involving Internet content delivery networks, resulting in 9-0 win and landmark ruling on divided infringement of method claims) (U.S. Supreme Court; 134 S.Ct. 2111 (2014)).
  • Wireless Ink Corp. v. Google, Inc. et al. (argued on behalf of Facebook and Google in Federal Circuit in case involving technology for managing Web sites designed to be accessed from mobile devices; successfully defended judgment of noninfringement) (Fed. Cir. 2014) (Nos. 2013-1683, 2013-1684).
  • Greenville Communications, L.L.C. v. Cellco Partnership d/b/a Verizon Wireless, (represented Verizon Wireless in obtaining favorable claim construction ruling and stipulated judgment of non-infringement in case involving wireless telephone calling features; successfully defended judgment on appeal) (D.N.J. 2012) (3:07-cv-4222) (Fed. Cir. 2013) (No. 2012-1676).
  • In re Gabapentin Patent Litigation (represented Teva Pharmaceuticals in jury trial of high-stakes patent infringement case involving drug for treatment of epilepsy; case settled on favorable terms two weeks into trial) (D.N.J. 2011) (MDL No. 1384).
  • Ricoh Co., Ltd. v. Quanta Computer, Inc. (successfully represented plaintiff Ricoh in obtaining reversal on appeal of unfavorable summary judgment ruling in patent infringement case brought against Taiwanese maker of optical disc drives; on remand, obtained $14.5 million jury verdict for patentee) (Fed. Cir. 2008) (550 F.3d 1325) (W.D. Wis. 2010) (No. 06-cv-462-bbc).

Accolades

  • Best Lawyers, “The Best Lawyers in America®” (2024 – 2023)
  • LMG Life Sciences, “Hatch-Waxman Litigator of the Year – Generic” (2023)
  • IAM Patent 1000, “Washington, DC: Patent Litigation (Silver and Bronze Bands)” (2023 – 2018)
  • LMG Life Sciences, “Finalist – Hatch-Waxman Litigator of the Year – Generic” (2022, 2020)
  • World Intellectual Property Review (WIPR), “WIPR Leaders” (2023 – 2022)
  • Managing IP, “IP Star” (2023 – 2019)
  • LMG Life Sciences, “Life Sciences Star” (2023 – 2019)
  • LMG Life Sciences, “Hatch-Waxman Litigator of the Year” (2021)
  • Super Lawyers, “Super Lawyer – Washington, DC” (2024 – 2020)
  • Patexia, “100 Best Performing CAFC Attorneys Representing Appellees (Top 50)” (2022)

Education

  • J.D., The University of Texas School of Law, with highest honors
  • M.A., Oxford University, Brasenose College, with first-class honors
  • B.A., The University of Texas at Austin, with highest honors

Admissions

  • District of Columbia
  • Supreme Court of the United States
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. Court of Appeals for the Fourth Circuit
  • U.S. Court of Appeals for the Ninth Circuit
  • U.S. District Court for the District of Columbia
  • Virginia

Clerkships

  • Supreme Court of the United States
  • U.S. Court of Appeals for the District of Columbia Circuit

Languages Spoken

  • French
  • German

Events

Speaking Engagement 15th Summit on Biosimilars & Innovator Biologics New York, NY, June 20, 2024
Speaking Engagement 20th Paragraph IV Disputes Conference New York, NY, April 25, 2024
Speaking Engagement The U.S. Patent Landscape Virtual, September 15, 2020
Speaking Engagement 2019 Global IP Strategy Conference Washington, DC, March 15, 2019
Speaking Engagement 2018 Global IP Strategy Conference Washington, DC, March 9, 2018

Related Resources From John Christopher "J.C." Rozendaal

Press Release Eighteen Sterne Kessler Attorneys Recognized as 2024 “Super Lawyers” and “Rising Stars” Sterne, Kessler, Goldstein & Fox April 25, 2024
Firm Announcements Sterne Kessler Secures Victory on Behalf of Teva Pharmaceuticals Sterne, Kessler, Goldstein & Fox April 24, 2024
In the News US Supreme Court Denies Vanda's Bid to Revive Sleep Drug Patents Life Sciences Intellectual Property Review April 23, 2024
In the News Petition Watch: Patent Obviousness, ADA Trials, Spoofing Law360 January 25, 2024
In the News Teva Defeats Infringement Claims on Endocrine Drug New Jersey Law Journal January 3, 2024
Firm Announcements Federal Circuit Affirms Sweet Win for SweeGen in Patent Invalidity Battle Sterne, Kessler, Goldstein & Fox January 3, 2024
Firm Announcements Sterne Kessler Secures Non-Infringement Win for Teva Pharmaceuticals Sterne, Kessler, Goldstein & Fox January 3, 2024
In the News Fed. Circ. Judge Casts Doubt On Sweetener Enzyme Patents Law360 November 7, 2023
Press Release Sterne Kessler Notches Multiple Rankings in 2024 “Best Law Firms” List Sterne, Kessler, Goldstein & Fox November 6, 2023
Press Release LMG Life Sciences Ranks Sterne Kessler and Seven Directors for Patent Litigation and Prosecution Sterne, Kessler, Goldstein & Fox September 21, 2023
Press Release Sterne Kessler Presented With Two Top Honors at 2023 LMG Life Sciences Americas Awards Sterne, Kessler, Goldstein & Fox September 8, 2023
Firm Announcements U.S. District Court Affirms Immigrant Children’s Constitutional Rights Sterne, Kessler, Goldstein & Fox August 29, 2023
In the News Shibuya Sheds $38 Million Patent Loss With Noninfringement Order Bloomberg Law March 15, 2023
In the News Teva, Apotex Win Ax of Patents in Sleep Drug Suit Law360 December 13, 2022
In the News Patexia Insight 161: Top CAFC Law Firms of 2022 Patexia December 1, 2022
In the News Korean Co. Can't Be First To Invent CRISPR, PTAB Told Law360 September 12, 2022
Firm Announcements Sterne Kessler Raises Over $34,000 for the Legal Aid Society of the District of Columbia Sterne, Kessler, Goldstein & Fox August 8, 2022
Press Release Four Sterne Kessler Directors Named “WIPR Leaders” By World Intellectual Property Review Sterne, Kessler, Goldstein & Fox June 2, 2022
In the News Stevia Patent Claims Fall After SweeGen Challenge Law360 May 24, 2022
Press Release Super Lawyers Recognizes 14 Attorneys as 2022 “Super Lawyers” and “Rising Stars” Sterne, Kessler, Goldstein & Fox May 1, 2022
In the News Litigator of the Week Runners-Up and Shout Outs Law.com February 18, 2022
In the News Federal Circuit Tosses Naloxone Patents Law Street Media February 11, 2022
In the News Teva Win Invalidating Narcan Patents Upheld by Federal Circuit Bloomberg Law February 10, 2022
In the News Split Fed. Circ. Won't Restore 4 Narcan Patents Law360 February 10, 2022
In the News Tribunal Rule Among Top Patent Litigation Issues Going Into 2022 Bloomberg Law December 28, 2021
Press Release Sterne Kessler and Seven Directors Earn Top-Tier Designations in 2021 LMG Life Sciences Rankings Sterne, Kessler, Goldstein & Fox September 29, 2021
Press Release Directors Ellison, Rozendaal, and Sterling Win Prominent LMG Life Sciences Americas Awards Sterne, Kessler, Goldstein & Fox September 23, 2021
In the News AbbVie Settles Patent Dispute Over Muscle Stimulation Tech Law360 September 7, 2021
In the News Adapt Faces Tough Questions in Bid to Revive Narcan Patents Bloomberg Law August 2, 2021
In the News IP Forecast: Fed. Circ. To Mull Narcan Patents Law360 July 29, 2021
In the News Patent Litigation Trends To Watch In 2021 Law360 January 3, 2021
In the News Justices Skip Case Horizon Said Puts 32K Patents At Risk Law360 November 3, 2020
Press Release Sterne Kessler Client Wins 2020 Nobel Prize in Chemistry for CRISPR-Cas9 Technology Sterne, Kessler, Goldstein & Fox P.L.L.C. October 8, 2020
Press Release Firm and Seven Directors Recognized in 2020 LMG Life Sciences Rankings Sterne, Kessler, Goldstein & Fox P.L.L.C. October 6, 2020
Press Release Sterne, Kessler, Goldstein & Fox Wins Two 2020 LMG Life Sciences Americas Awards Sterne, Kessler, Goldstein & Fox P.L.L.C. September 24, 2020
Press Release Sterne, Kessler, Goldstein & Fox and 15 Directors Earn Top Rankings in IAM Patent 1000 Sterne, Kessler, Goldstein & Fox P.L.L.C. June 16, 2020
In the News Teva Invalidates Opiant Patents In Narcan Suit Law360 June 5, 2020
Press Release Sterne Kessler Ranked and 13 Directors Named “IP Stars” by Managing Intellectual Property Sterne, Kessler, Goldstein & Fox P.L.L.C. May 5, 2020
Press Release Sterne, Kessler, Goldstein & Fox Attorneys Named 2020 Super Lawyers and Rising Stars Sterne, Kessler, Goldstein & Fox P.L.L.C. April 30, 2020
Press Release Sterne Kessler Again Receives Sole Band 1 Chambers Ranking for Patent Prosecution Among D.C. Firms Sterne, Kessler, Goldstein & Fox P.L.L.C. April 24, 2020
In the News Rival Says Allergan Muscle Toner Not As Strong As Claimed Law360 February 20, 2020
In the News Teva Gets PTAB To Review Cushing's Syndrome Drug Patent Law360 November 21, 2019
In the News PTAB Cuts Down Two More Allergan Restasis Patents Law360 September 30, 2019
Press Release Sterne Kessler Prominent Again in Intellectual Asset Management Magazine’s "IAM Patent 1000" Sterne, Kessler, Goldstein & Fox P.L.L.C June 12, 2019
In the News Supreme Court Refuses 'Blocking Patent' Rule Case Law360 June 3, 2019
In the News Law Firms: Legal Actions, Decisions Bloomberg Law April 29, 2019
In the News Managing IP America Awards 2019 Winners Revealed Managing Intellectual Property April 8, 2019
In the News Fed. Circ. Won't Revisit Restasis Patent Ruling Law360 April 6, 2019
In the News Fed. Circ. Won't Revisit Restasis Patent Ruling Law360 March 6, 2019
In the News Restasis Patent Redo Bid 'Inappropriate,' Fed. Circ. Told Law360 February 15, 2019
In the News Golf Club Makers Settle Sprawling 23-Patent Suit Law360 February 4, 2019
Press Release Lawsuit Filed on Behalf of 10K Detained Children fivejars January 22, 2019
In the News Lawsuit Filed on Behalf of 10K Detained Children fivejars January 22, 2019
In the News Challenge To Immigrant Minors Detention Policy Expands Law360 January 22, 2019
In the News Fed. Circ. Erases Seoul Semiconductor's $4M Patent Award Law360 November 19, 2018
In the News Challenge to ORR Child Detention Policy Legal Aid Justice Center November 16, 2018
In the News Challenge To Refugee Office Procedures Mostly Survives Law360 November 15, 2018
In the News Fed. Circ. Won't Restore Allergan's Restasis Patent Claims Law360 November 13, 2018
In the News Fed. Circ. Urged Not to Stay Immunity Ruling for Appeal Law360 November 6, 2018
In the News Allergan, Generic Cos. Battle Over Restasis Launch Plans Law360 October 31, 2018
In the News Fed. Circ. Rejects Bid For PTAB Tribal Immunity Rehearing Law360 October 22, 2018
In the News No Need To Reconsider Immunity At PTAB, Fed. Circ. Hears Law360 September 19, 2018
In the News Fed. Circ. Impeding Biopharma Innovation, Justices Told Law360 August 29, 2018
Firm Announcements Sterne Kessler Prevails in the Release of Child from a Juvenile Detention Center Sterne, Kessler, Goldstein & Fox July 26, 2018
In the News Fed. Circ. Says Tribal Immunity Doesn't Apply In IPR Law360 July 20, 2018
In the News Patent Litigation Trends To Watch In 2018 Law360 January 1, 2018
In the News Analysing SCOTUS Oral Arguments in Oil States and SAS Institute Managing Intellectual Property December 6, 2017
In the News Prison Phone Rivals Reach Confidential Deal in IP Row Law360 December 5, 2017
In the News Sterne Kessler Adds 2 Kellogg Huber IP Pros as Directors Law360 January 30, 2017
In the News Washington-Area Appointments and Promotions for Jan. 30 The Washington Post January 29, 2017
In the News Sterne, Kessler, Goldstein & Fox Adds Directors World Intellectual Property Review January 26, 2017
Press Release Litigators J.C. Rozendaal and Mike Joffre Join Sterne Kessler fivejars January 25, 2017